A novel approach to glioma therapy using an oncolytic adenovirus with two specific promoters.

Liu, Feng; Xu, Kaya; Yang, Hua; Li, Yuming; Liu, Jian; Wang, Jixiang; Guan, Zhizhong

Liu, Feng; Xu, Kaya; Yang, Hua; Li, Yuming; Liu, Jian; Wang, Jixiang; Guan, Zhizhong.

Afiliação

Liu F; Department of Neurosurgery, The Hospital Affiliated to Guizhou Medical University, Guiyang, Guizhou 550000, P.R. China.
Xu K; Department of Neurosurgery, The Hospital Affiliated to Guizhou Medical University, Guiyang, Guizhou 550000, P.R. China.
Yang H; Department of Neurosurgery, The Hospital Affiliated to Guizhou Medical University, Guiyang, Guizhou 550000, P.R. China.
Li Y; Department of Neurosurgery, The Hospital Affiliated to Guizhou Medical University, Guiyang, Guizhou 550000, P.R. China.
Liu J; Department of Neurosurgery, The Hospital Affiliated to Guizhou Medical University, Guiyang, Guizhou 550000, P.R. China.
Wang J; Department of Neurosurgery, The Hospital Affiliated to Guizhou Medical University, Guiyang, Guizhou 550000, P.R. China.
Guan Z; Department of Molecular Biology, The Laboratory of Molecular Biology, Guizhou Medical University, Guiyang, Guizhou 550000, P.R. China.

Oncol Lett ; 15(3): 3362-3368, 2018 Mar.

Article em En | MEDLINE | ID: mdl-29435080

Palavras-chave

conditionally replicative adenovirus; early viral 1A; glial fibrillary acidic protein; human telomerase reverse transcriptase; p53

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncol Lett Ano de publicação: 2018 Tipo de documento: Article País de publicação: Grécia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google